Showing 1841-1850 of 2150 results for "".
- SAV-IOL Continues Progress on Electronic IOL Projecthttps://modernod.com/news/sav-iol-continues-progress-on-electronic-iol-project/2480946/SAV-IOL (Swiss Advanced Vision) provided an update on its progress toward making the first active, electronic IOL through their R-TASC Project. SAV-IOL first launched the R-TASC Project idea in 2018. "Current IOLs on the market suffer
- Phase 3 Clinical Study IND Accepted in China for Alimera’s Fluocinolone Acetonide Intravitreal Implanthttps://modernod.com/news/phase-3-clinical-study-ind-accepted-in-china-for-alimeras-fluocinolone-acetonide-intravitreal-implant/2480901/Alimera Sciences announced that its partner, Ocumension Therapeutics, received approval from the National Medical Products Administration for its IND application to begin the phase 3 clinical study for fluocinolone acetonide intravitreal implant in support of a filing for marketing approval
- Staar Surgical Celebrates 2 Million Lens Milestone for Implantable Collamer Lens (ICL)https://modernod.com/news/staar-surgical-celebrates-2-million-lens-milestone-for-implantable-collamer-lens-icl/2480897/Staar Surgical announced that more than 2 million Visian Implantable Collamer lenses (ICLs) have been sold globally, including more than one and a half million of the company’s latest generation of implantable lenses–EVO Visian ICLs (EVO). New to the U.S. market, E
- SAV-IOL Launches Instant Focus EDOF IOL Technologyhttps://modernod.com/news/sav-iol-launches-instant-focus-edof-iol-technology/2480841/Instant Focus is a unique optical technology designed by Swiss IOL maker SAV-IOL (Swiss Advanced Vision). The technology is designed to replace the accommodative function of the eye’s natural lens after cataract surgery, and is manufactured and marketed directly from their he
- Medevise Consulting Announces Board of Directors and First Subsidiaryhttps://modernod.com/news/medevise-consulting-announces-board-of-directors-and-first-subsidiary/2480781/On its first anniversary, Medevise Consulting, a provider of ophthalmology innovation and market strategy in Europe, anno
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack Advancehttps://modernod.com/news/nova-eye-medical-launches-next-generation-canaloplasty-device-for-glaucoma-itrack-advance/2480774/Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific. The iTrack Advance features the proprietary illuminated fiber optic tip of the original iTrack device, which all
- iSTAR Medical Announces First MINIject Surgeries Performed in the UKhttps://modernod.com/news/istar-medical-announces-first-miniject-surgeries-performed-in-the-uk/2480727/iSTAR Medical announced that it has further expanded its commercial rollout for MINIject to the UK. MINIject is iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) implant and currently the only commercially available supraciliary MIGS device. With this market exp
- I-Med Pharma USA Partners With DryEye Rescue to Distribute Its Dry Eye Product Portfolio in the United Stateshttps://modernod.com/news/i-med-pharma-usa-partners-with-dryeye-rescue-to-distribute-its-dry-eye-product-portfolio-in-the-united-states/2480614/With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with DryEye Rescue of Boca Raton, Florida to distribute and market their dry eye product portfolio. DryEye Rescue will help raise awareness of
- Global Data: Primary Open Angle Glaucoma Total Prevalent Cases to Reach 8.84 Million by 2030https://modernod.com/news/global-data-primary-open-angle-glaucoma-total-prevalent-cases-to-reach-884-million-by-2030/2480534/The burden of total prevalent cases (diagnosed and undiagnosed) of primary open angle glaucoma (POAG) is expected to increase at an annual growth rate (AGR) of 2% from around 7.3 million cases in 2020 to 8.84 million in 2030 in the seven major markets, according to GlobalData. The increase is par
- New Technology, Greater Patient Awareness Will Help Drive Gains in Premium Cataract Surgeryhttps://modernod.com/news/new-technology-greater-patient-awareness-will-help-drive-gains-in-premium-cataract-surgery/2480489/Gains in the premium cataract surgery market over the next 5 years will be driven by technological improvements, growing value awareness among patients, declining reimbursement in the public